Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity".

Bhattacharyya, Sumit; Xie, Hui; Dodda, Amar; Varady, Krista A; Feferman, Leo; Halline, Allan G; Hanauer, Stephen B; Tobacman, Joanne K

Bhattacharyya, Sumit; Xie, Hui; Dodda, Amar; Varady, Krista A; Feferman, Leo; Halline, Allan G; Hanauer, Stephen B; Tobacman, Joanne K.

Afiliação

Bhattacharyya S; Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Xie H; Jesse Brown VA Medical Center, Chicago, IL, USA.
Dodda A; Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL, USA.
Varady KA; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Feferman L; Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Halline AG; Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.
Hanauer SB; Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Tobacman JK; Jesse Brown VA Medical Center, Chicago, IL, USA.

Nutr Healthy Aging ; 5(2): 159-163, 2019.

Article em En | MEDLINE | ID: mdl-31922053

ABSTRACT

ABSTRACT

This article is an invited response to a critique by industry of our published study about the impact of carrageenan supplement on the interval to relapse in ulcerative colitis patients on a no-carrageenan diet.

Palavras-chave

Carrageenan; inflammation; log-rank test; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Nutr Healthy Aging Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google